Stillbirth in the Pregnancy Complicated by Diabetes

  • Roman Starikov
  • Donald Dudley
  • Uma M. ReddyEmail author
Diabetes and Pregnancy (CJ Homko, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Diabetes and Pregnancy


Pregestational diabetes currently complicates 4 % of pregnancies, while gestational diabetes complicates approximately 8 % of pregnancies. Increased risk of stillbirth in diabetic pregnancies has been a well-known and recognized complication for decades. While stillbirth rates for diabetic pregnancies have decreased due to screening, treatment, and antenatal surveillance of these patients, about 4 % of all stillbirths remain attributable to diabetes, and diabetic pregnancies continue to be at increased risk for perinatal mortality. The purpose of this article is to review the literature on the epidemiology, pathophysiology, and prevention, as well as future research, of diabetes-associated perinatal mortality.


Stillbirth Pregestational diabetes mellitus Gestational diabetes mellitus Hemoglobin A1c Hyperglycemia Hypoglycemia 


Compliance with Ethics Guidelines

Conflict of Interest

Roman Starikov, Donald Dudley, and Uma M. Reddy declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Williams J. The clinical significance of glycosuria in pregnancy women. Am J Med Sci. 1909;137:1.CrossRefGoogle Scholar
  2. 2.
    Roman AS, Rebarber A, Fox NS, Klauser CK, et al. The effect of maternal obesity on pregnancy outcomes in women with gestational diabetes. J Matern Fetal Neonatal Med. 2011;24:723–7.CrossRefPubMedGoogle Scholar
  3. 3.
    Nohr EA, Villamor E, Vaeth M, et al. Mortality in infants of obese mothers: is risk modified by mode of delivery? Acta Obstet Gynecol Scand. 2012;91:363–71.CrossRefPubMedGoogle Scholar
  4. 4.
    Chu S, Kim S, Lau J, et al. Maternal obesity and risk of stillbirth: a meta-analysis. Am J Obstet Gynecol. 2007;197:223–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Smith GC, Pell JP, et al. Caesarean section and risk of unexplained stillbirth in subsequent pregnancy. Lancet. 2003;362:1779–84.CrossRefPubMedGoogle Scholar
  6. 6.
    Gray R, Quigley M, Hockley C, et al. Caesarean delivery and risk of stillbirth in subsequent pregnancy: a retrospective cohort study in an English population. BJOG. 2007;114:264–70.CrossRefPubMedGoogle Scholar
  7. 7.
    Reddy UM, Ko CW, Willinger M. Maternal age and the risk of stillbirth throughout pregnancy in the United States. Am J Obstet Gynecol. 2006;195:764–70.CrossRefPubMedGoogle Scholar
  8. 8.
    Canterino JC, Ananth CV, Smulian J, et al. Maternal age and risk of fetal death in singleton gestations: USA, 1995-2000. J Matern Fetal Neonatal Med. 2004;15:193–7.CrossRefPubMedGoogle Scholar
  9. 9.
    Bahtiyar MO, Funai EF, Rosenberg V, et al. Stillbirth at term in women of advanced maternal age in the United States: when could the antenatal testing be initiated? Am J Perinatol. 2008;25:301–4.CrossRefPubMedGoogle Scholar
  10. 10.•
    Frey HA, Odibo AO, Dicke JM, et al. Stillbirth risk among fetuses with ultrasound-detected isolated congenital anomalies. Obstet Gynecol 2014 Jun 4. [Epub ahead of print]. Excellent study that compares stillbirth risks in fetuses with and without ultrasound diagnosed congenital abnormalities.Google Scholar
  11. 11.
    Pauli RM, Reiser CA, Lebovitz RM, Kirkpatrick SJ. Wisconsin Stillbirth Service Program: I. Establishment and assessment of a community-based program for etiologic investigation of intrauterine deaths. Am J Med Genet. 1994;50:116–34.CrossRefPubMedGoogle Scholar
  12. 12.
    Laury A, Sanchez-Lara PA, Pepkowitz S, et al. A study of 534 fetal pathology cases from prenatal diagnosis referrals analyzed from 1989 through 2000. Am J Med Genet A. 2007;143A:3107–20.CrossRefPubMedGoogle Scholar
  13. 13.
    Korteweg FJ, Bouman K, Erwich JJ, et al. Cytogenetic analysis after evaluation of 750 fetal deaths: proposal for diagnostic workup. Obstet Gynecol. 2008;111:865–74.CrossRefPubMedGoogle Scholar
  14. 14.•
    Trudell AS, Cahill AG, Tuuli MG, et al. Risk of stillbirth after 37 weeks in pregnancies complicated by small-for-gestational-age fetuses. Am J Obstet Gynecol. 2013;208:376. This is more recent study confirming previous studies that small for age fetuses are at increased risk for stillbirth.CrossRefPubMedGoogle Scholar
  15. 15.
    Clausson B, Gardosi J, Francis A, et al. Perinatal outcome in SGA births defined by customised versus population-based birthweight standards. BJOG. 2001;108:830–4.PubMedGoogle Scholar
  16. 16.
    Ego A, Subtil D, Grange G, et al. Customized versus population-based birth weight standards for identifying growth restricted infants: a French multicenter study. Am J Obstet Gynecol. 2006;194:1042–9.CrossRefPubMedGoogle Scholar
  17. 17.
    Standards of medical care in diabetes--2011. American Diabetes Association. Diabetes Care. 2011;34(0suppl 1):S11–61.Google Scholar
  18. 18.
    Metzger BE, Gabbe SG, Persson B, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Int Assoc Diabetes Pregnancy Study Groups Consensus Panel Diabetes Care. 2010;33:676–82.Google Scholar
  19. 19.
    Gestational diabetes mellitus. Practice Bulletin No. 137. American College of Obstetricians and Gynecologists. Obstet Gynecol 2013; 122:406–16.Google Scholar
  20. 20. accessed on 6/14/14.
  21. 21.
    Lauenborg J, Mathiesen E, Oveson P, et al. Audit of stillbirth in women with pregestational type 1 diabetes. Diabetes Care. 2003;26:1385–9.CrossRefPubMedGoogle Scholar
  22. 22.
    Eidem I, Vangen S, Hanssen KF, et al. Perinatal and infant mortality in term and preterm births among women with type 1 diabetes. Diabetologia. 2011;54:2771–8.CrossRefPubMedGoogle Scholar
  23. 23.
    Persson M, Norman M, Hanson U. Obstetric and perinatal outcomes in type 1 diabetic pregnancies. Diabetes Care. 2009;32:2005–9.CrossRefPubMedCentralPubMedGoogle Scholar
  24. 24.
    Jensen D, Damm P, Moelsted-Pedersen L, et al. Outcomes in type 1 diabetic pregnancies. Diabetes Care. 2004;27:2819–23.CrossRefPubMedGoogle Scholar
  25. 25.
    Dos Satos SI, Higgins C, Swerdlow AJ, et al. Birthweight and other pregnancy outcomes in a cohort of women with pregestational insulin-treated diabetes mellitus, Scotland, 1979-1995. Diabet Med. 2005;22:440–7.CrossRefGoogle Scholar
  26. 26.
    Penney G, Mair G, Pearson DWM. Outcomes of pregnancies in women with type 1 diabetes in Scotland: a national population-based study. BJOG. 2003;110:315–8.CrossRefPubMedGoogle Scholar
  27. 27.
    Casson IF, Clarke CA, Howard CV, et al. Outcomes in pregnancy in insulin dependent diabetic women: results of a five year population cohort study. Br Med J. 1997;315:275–8.CrossRefGoogle Scholar
  28. 28.
    Cundy T, Gamble G, Townende K, et al. Perinatal mortality in type 2 diabetes mellitus. Diabet Med. 2000;17:33–9.CrossRefPubMedGoogle Scholar
  29. 29.
    Clausen TD, Matiesen E, Ekbom P, et al. Poor pregnancy outcome in women with type 1. Diabet Care. 2005;28:323–8.CrossRefGoogle Scholar
  30. 30.
    de Valk HW, van Nieuwaal NH, Visser GH. Pregnancy outcome in type 2 diabetes mellitus: a retrospective analysis form the Netherlands. Rev Diabet Stud. 2006;3:134–42.CrossRefPubMedCentralPubMedGoogle Scholar
  31. 31.
    Dunne F, Brydon P, Smith K, et al. Pregnancy in women with type 2 diabetes: 12 years outcome data 1990-2002. Diabet Med. 2003;20:734–8.CrossRefPubMedGoogle Scholar
  32. 32.
    Macintosh MC, Fleming KM, Bailey JA, et al. Perinatal mortality and congenital anomalies in babies of women of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ. 2006;333:177.CrossRefPubMedCentralPubMedGoogle Scholar
  33. 33.
    Hawthorne G, Robson S, Ryall EA, et al. Prospective population based survey of outcome of pregnancy in diabetic women: results of the Northern Diabetic Pregnancy Audit, 1994. BMJ. 1997;315:279–81.CrossRefPubMedCentralPubMedGoogle Scholar
  34. 34.
    Boulot P, Chabbert-Buffet N, d’Ercole C, et al. French multicentric survey of outcome of pregnancy in women with pregestational diabetes. Diabetes Care. 2003;26:2990–3.CrossRefPubMedGoogle Scholar
  35. 35.
    Balsells M, Garcia-Patterson A, Gich I, et al. Maternal and fetal outcome in women with type 2 versus 1 diabetes mellitus: a systematic review and metaanalysis. J Clin Endocrinol Metab. 2009;94:4284–91.CrossRefPubMedGoogle Scholar
  36. 36.
    O’Sullivan JB, Charles D, Mahan CM, et al. Gestation diabetes and perinatal mortality rate. Am J Obstet Gynecol. 1973;116:901–4.PubMedGoogle Scholar
  37. 37.
    White BM, Beischer NA. Perinatal mortality in the infants of diabetic women. Aust N Z J Obstet Gynaecol. 1996;36:239–47.CrossRefGoogle Scholar
  38. 38.
    Aberg A, Rydhstrom H, Kallen B, et al. Impaired glucose tolerance during pregnancy is associated with increased fetal mortality in preceding sibs. Acta Obstet Gynecol Scand. 1997;76:212–7.CrossRefPubMedGoogle Scholar
  39. 39.
    Wood SL, Jick H, Sauve R. The risk of stillbirth in pregnancies before and after the onset of diabetes. Diabet Med. 2003;20:703–7.CrossRefPubMedGoogle Scholar
  40. 40.
    Beisher NA, Wein P, Sheedy MT, et al. Identification and treatment of women with hyperglycemia diagnosed during pregnancy can significantly reduce perinatal mortality rates. Aust N Z J Obstet Gyneecol. 1996;36:239–47.CrossRefGoogle Scholar
  41. 41.
    Lapolla A, Dalfra MG, Bonomo M, et al. Gestational diabetes mellitus in Italy: a multicenter study. Eur J Obstet Gynecol Reprod Biol. 2009;145:149–53.CrossRefPubMedGoogle Scholar
  42. 42.
    Langer O, Yogev Y, Most O, et al. Gestational diabetes: the consequences of not treating. Am J Obstet Gynecol. 2005;192:989–97.CrossRefPubMedGoogle Scholar
  43. 43.
    Langdon MB, Spong CY, Thom E, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009;361:1339–48.CrossRefGoogle Scholar
  44. 44.
    Mondestin MAJ, Ananth CV, et al. Birth weight and fetal death in the United States: the effect of maternal diabetes during pregnancy. Am J Obstet Gynecol. 2002;187:922–6.CrossRefPubMedGoogle Scholar
  45. 45.
    Desoye F, Kaufman P. The human placenta in diabetes. In Parta M, Matschinsky FM (eds.) Diabetology of pregnancy. Basel: Karger 2006; 94-109.Google Scholar
  46. 46.
    Hiden U, Glitzner E, Hartmann M, et al. Insulin and the IGF system in the human placenta of normal and diabetic pregnancies. J Anat. 2009;215:60–8.CrossRefPubMedCentralPubMedGoogle Scholar
  47. 47.•
    Reece EA. Diabetes-induced birth defects: what do we know? What can we do? Curr Diab Rep. 2012;12:24–32. Excellent summary of pathogenesis and congenital abnormalities in pregnancies complicated by gestational diabetes.CrossRefPubMedGoogle Scholar
  48. 48.••
    The Stillbirth Collaborative Research Network Writing Group. Causes of death among stillbirth. JAMA. 2011;306:2459–68. This is a landmark paper that summarizes utility and each test after diagnosis of stillbirth.CrossRefGoogle Scholar
  49. 49.
    Scheimberg I. The genetic autopsy. Curr Opin Pediatr. 2013;25:659–65.CrossRefPubMedGoogle Scholar
  50. 50.
    Dudley DJ. Diabetic-associated stillbirth: incidence, pathophysiology, and prevention. Obstet Gynecol Clin N Am. 2007;34:293–307.CrossRefGoogle Scholar
  51. 51.
    Bradley RJ, Brudenell JM, Nicolaides KH. Fetal acidosis and hyperlacticaemenia diagnose by cordocentesis in pregnancies complicated by diabetes mellitus. Diabet Med. 1991;8:464–8.CrossRefPubMedGoogle Scholar
  52. 52.
    Salvesen DR, Brudenell JM, Nicolaides KH. Prediction and fetal acidaemia in pregnancies complicated by maternal diabetes mellitus by biophysical profile scoring and fetal heart rate monitoring. BJOG. 1993;100:227–33.CrossRefGoogle Scholar
  53. 53.
    Datta S, Jr Brown WU. Acid-base status in diabetic mothers and their infants following general or spinal anesthesia for cesarean section. Anesthesiology. 1977;47:272–6.CrossRefPubMedGoogle Scholar
  54. 54.
    Rosenn BM, Miodovnik M, Holcberg G, et al. Hypoglycemia: the price of intensive insulin therapy for pregnant women with insulin dependent diabetes mellitus. Obstet Gynecol. 1995;85:417–22.CrossRefPubMedGoogle Scholar
  55. 55.
    Rosenn BM, Miodovnik M. Glycemic control in diabetic pregnancy: is tighter always better? J Matern Fetal Med. 2000;9:29–34.CrossRefPubMedGoogle Scholar
  56. 56.
    Chandler KD, Leury BJ, Bird AR, et al. Effects of undernutrition and exercise during late pregnancy on uterine, fetal and uteroplacental metabolism in the ewe. Br J Nutr. 1985;53:625–35.CrossRefPubMedGoogle Scholar
  57. 57.
    Veille JC, Sivakoff M, Hanson R, et al. Interventricular septal thickness in fetuses of diabetic mothers. Obtet Gynecol. 1992;79:51–4.Google Scholar
  58. 58.
    Russell NE, Holloway P, Quinn S, et al. Cardiomyopathy and cardiomegaly in stillborn of infants of diabetic mothers. Pediatr Dev Pathol. 2008;11:10–1.CrossRefPubMedGoogle Scholar
  59. 59.
    Abu-Sulaiman RM, Subaih B. Congenital heart disease in infants of diabetic mothers: echocardiographic study. Pediatr Cardiol. 2004;25:137–40.CrossRefPubMedGoogle Scholar
  60. 60.
    Correa A, Gilboa SM, Besser LM, et al. Diabetes mellitus and birth defects. Am J Obstet Gynecol. 2008;199:237. e1-9.CrossRefPubMedGoogle Scholar
  61. 61.
    Becerra JE, Khoury MJ, Cordero JF, et al. Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study. Pediatrics. 1990;85:1–9.PubMedGoogle Scholar
  62. 62.
    Wren C, Birrell G, Hawthorne G. Cardiovascular malformations in infants of diabetic mothers. Heart. 2003;89:1217–20.CrossRefPubMedCentralPubMedGoogle Scholar
  63. 63.
    Piper JM, Lander O. Does maternal diabetes delay fetal pulmonary maturity? Am J Obstet Gynecol. 1993;168:783–6.CrossRefPubMedGoogle Scholar
  64. 64.
    Piper JM, Xenakis EMJ, Langer O. Delayed appearance of pulmonary maturation markers is associated with poor glucose control in diabetic pregnancies. J Matern-Fetal Med. 1998;7:148–53.CrossRefPubMedGoogle Scholar
  65. 65.
    Diabetes care and research in Europe: the Saint Vincent declaration. Diabetic Med 1990;7:360.Google Scholar
  66. 66.
    Hadden DR, Alexander A, McCance DR, et al. Obstetric and diabetic care for pregnancy in diabetic women: 10 years outcome analysis, 1985-1995. Diabet Med. 2001;18:546–53.CrossRefPubMedGoogle Scholar
  67. 67.
    Roberts JM. Pathophysiology of ischemic placental disease. Semin Perinatol. 2014;38:139–45.CrossRefPubMedGoogle Scholar
  68. 68.
    Friedman AM, Cleary KL. Prediction and prevention of ischemic placental disease. Semin Perinatol. 2014;38:139–45.CrossRefGoogle Scholar
  69. 69.
    Poston L, Briley AL, Seed PT, et al. Vitamins and pre-eclampsia trial C. Vitamins C and E in pregnant women at risk for pre-eclampsia (VIP trial): randomized placebo-controlled trial. Lancet. 2006;367:1145–54.CrossRefPubMedGoogle Scholar
  70. 70.
    Villar J, Purvar M, Merialdi M, et al. World Health Organisation multicentre randomized trial of supplementation with vitamins C and E among pregnant women at risk for preeclampsia in populations of low nutritional status from developing countries. BJOG. 2009;116:780–8.CrossRefPubMedGoogle Scholar
  71. 71.
    Rumbold AR, Crowther CA, Haslam RR, et al. Vitamins C and E and the risks of preeclampsia and perinatal complications. N Engl J Med. 2006;354:1796–806.CrossRefPubMedGoogle Scholar
  72. 72.
    Roberts JM, Myatt L, Spong CY, et al. Vitamins C and E to prevent complication of pregnancy associated hypertension. N Engl J Med. 2010;362:1282–91.CrossRefPubMedCentralPubMedGoogle Scholar
  73. 73.
    Roberge S, Nicolaides KH, Demers S, et al. Prevention of perinatal death and adverse perinatal outcome using Low-dose aspirin: a meta-analysis. Ultrasound Obstet Gynecol. 2013;41:491–9.CrossRefPubMedGoogle Scholar
  74. 74.
    Henderson JT, Whitlock EP, O’Connor E, et al. Aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Inter Med. 2014;160:695–705.CrossRefGoogle Scholar
  75. 75.
    Miller E, Hare JW, Cloherty JP, Dunn PJ, et al. Elevated maternal hemoglobin A1c in early pregnancy and major congenital abnormalities in infants of diabetic mothers. N Engl J Med. 1981;304:1331–4.CrossRefPubMedGoogle Scholar
  76. 76.
    Starikov R, Bohrer J, Goh W, et al. Hemoglobin A1c in pregestational diabetic gravidas and the risk of congenital heart disease in the fetus. Pediatr Cardiol. 2013;34:1716–22.CrossRefPubMedGoogle Scholar
  77. 77.
    Ylinen K, Aula P, Stenman UH, et al. Risk of minor and major malformations in diabetics with high haemoglobin A1c values in early pregnancy. Br Med J. 1984;289:345–6.CrossRefGoogle Scholar
  78. 78.
    Nielsen GL, Sorenson PH, Neilsen PH, et al. Glycosylated hemoglobin as predictor of adverse fetal outcome in type 1 diabetic pregnancies. Acta Diabetol. 1997;34:217–22.CrossRefPubMedGoogle Scholar
  79. 79.
    Starikov R, Inman K, Chien EK, et al. Can hemoglobin A1c in early pregnancy predict adverse pregnancy outcomes in diabetic patients? J Diabetes Complications. 2014;28:203–7.CrossRefPubMedGoogle Scholar
  80. 80.
    Pregestational diabetes mellitus. Practice Bulletin No. 60. American College of Obstetricians and Gynecologists. Obstet Gynecol 2005;105:675-85.Google Scholar
  81. 81.
    Antepartum fetal surveillance. Practice Bulletin No 145. American College of Obstetricians and Gynecologist. Obstet Gynecol 2014; 124:182-192Google Scholar
  82. 82.
    Fetal macrosomia. Practice Bulletin No. 22. American College of Obstetricians and Gynecologists. Obstet Gynecol 2000.Google Scholar
  83. 83.
    Deter RL, Hadlock FP. Use of ultrasound in the detection of macrosomia: a review. J Clin Ultrasound. 1985;13:519–24.CrossRefPubMedGoogle Scholar
  84. 84.
    Rossavik IK, Joslin GL. Macrosomatia and ultrasonography: what is the problem? South Med J. 1993;86:1129–32.CrossRefPubMedGoogle Scholar
  85. 85.
    Sandmire HF. Whither ultrasonic prediction of fetal macrosomia? Obstet Gynecol. 1993;82:860–2.PubMedGoogle Scholar
  86. 86.
    Spong CY, Mercer BM, D’Alton M, et al. Timing of indicated late-preterm and early-term birth. Obstet Gynecol. 2011;118:323–33.CrossRefPubMedCentralPubMedGoogle Scholar
  87. 87.•
    Medically indicated late-preterm and early term deliveries. Committee Opinion No 560 American College of Obstetricians and Gynecologists. Obtet Gynecol 2013;121:908-10. This is very important document that summarizes timing of delivery for mothers with medical complications.Google Scholar
  88. 88.••
    Donofrio MT, Moon-Grady AJ, Hornberger LK, et al. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association. Circulation 2014 [Epub]. Executive summary of diagnosis and treatment of fetal cardiac diseases.Google Scholar
  89. 89.
    American Institute of Ultrasound in Medicine. AIUM practice guidelines for the performance of fetal echocardiography. J Ultrasound Med. 2013;32:1067–82.CrossRefGoogle Scholar
  90. 90.
    Yogev Y, Hod M. Use of new technologies for monitoring and treating diabetes in pregnancy. Obstet Gynecol Clin N Am. 2007;34:241–53.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.WashingtonUSA
  2. 2.Department of Obstetrics and GynecologyUniversity of VirginiaCharlottesvilleUSA

Personalised recommendations